{'text': 'AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal', 'publisher': {'href': 'https://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Thu, 05 Mar 2015 08:00:00 GMT', 'description': 'AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal  Reuters', 'url': 'https://news.google.com/rss/articles/CBMiyAFBVV95cUxOUXNtcEI2MDJOeUNDMnVmXzVmUF9jYTZsay1PM09wZncweTZHdGJ1aE4wQmhVa21COW5iMDJKX0hLSkNySXRsZ0c5NjBJLVFpQ0lDc2hLaWlDYWFDZkEtcG8wRnNhVXZTNHNMUDFMTS1hZEFDNHREd0pEWno3ZTAzcUFJM2E2cFNyNDJxMGpjMllsQjZaNFRGMXpnZERRMjEyMVowa2ZFRDhrQUJvSUtmT2NVRDQ0VTFWeGYwY1llZW9XaWZYRHhUVw?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Bored by golf and cancer cured, AbbVie CEO Gonzalez came back to work', 'publisher': {'href': 'https://www.chicagobusiness.com', 'title': "Crain's Chicago Business"}, 'created_at': 'Fri, 06 Mar 2015 08:00:00 GMT', 'description': "Bored by golf and cancer cured, AbbVie CEO Gonzalez came back to work  Crain's Chicago Business", 'url': 'https://news.google.com/rss/articles/CBMizwFBVV95cUxOVHpldGROQzZzZ1pTRzJkdkxoc19vVU5iak5JU3AwMFA3dlNiNU4yMVI0dURnMnE2Vm9UVzNlVWEzQVR3cXgyeDFRNzY4SVZkM2pZZ3pjSnZaOEFQdGNONlNINmNoV2JCZ0JpcmhtbjV5MlNhaUduUGVGbzBvLXc5RXBNVkkwQ0huY1J2Vi1TeFdjcUtzRm9LaGJVLXdUN1BZTjBORDRreUgwRDlIbjNwVHdrb0FzTWtRWEFhZ0tjNU03QTZHMmhCblZZTTJ1bHc?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'AbbVie to Buy Pharmacyclics in $21 Billion Deal', 'publisher': {'href': 'http://www.wsj.com', 'title': 'The Wall Street Journal'}, 'created_at': 'Thu, 05 Mar 2015 08:00:00 GMT', 'description': 'AbbVie to Buy Pharmacyclics in $21 Billion Deal  The Wall Street Journal', 'url': 'https://news.google.com/rss/articles/CBMijgFBVV95cUxPZ1NJS2dKLW5PMDAwTUFCR2VHdG0xZ2ltbmFWV1JxQmJBeThESjR0VGU2YWlkdlFyWXQ5WEF4Tmo1ZFUwTHBMOGRfMER1NEN4V3phNXNGUzA2MzFSQzgxQ0MwOGJYQ2VuMGtJUzdONkdDdEp5SU1Kbkx4VkNfcU5laUVSNTladDhwTGthRDR3?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'AbbVie\'s $21B deal for Pharmacyclics a "strategically compelling opportunity" - Chicago Sun', 'publisher': {'href': 'https://chicago.suntimes.com', 'title': 'Chicago Sun-Times'}, 'created_at': 'Thu, 05 Mar 2015 08:00:00 GMT', 'description': 'AbbVie\'s $21B deal for Pharmacyclics a "strategically compelling opportunity"  Chicago Sun-Times', 'url': 'https://news.google.com/rss/articles/CBMiygFBVV95cUxPcndYVUE1Mm1sQklqRklYMWlURjRWNkNUeVE5eEp1YlpFaVotbnlZQ0dOVDRRVFhHU0kxenhsX3p5b3hJbERYeVFwMjA5NGd5N1dYa3pILUt6N2NITDVwc2JDSDhyTWtiWldYT3QwV1k3NWd0VVROX056ZXRLWmRUTUkxVEJON3M1M0NuZXBodW1raGhqTF8tWm5BVWI3end2WjN0cEFBbGpJY3gtWFRCTS01SnZMd2Y4REdPTjlYdkplMk5fWXctSkt3?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Bored by Golf and Cancer Cured, AbbVie CEO Came Back to Work', 'publisher': {'href': 'https://www.bloomberg.com', 'title': 'Bloomberg'}, 'created_at': 'Thu, 05 Mar 2015 08:00:00 GMT', 'description': 'Bored by Golf and Cancer Cured, AbbVie CEO Came Back to Work  Bloomberg', 'url': 'https://news.google.com/rss/articles/CBMitAFBVV95cUxPdzlNTXpVUnFEN3BqSGNwbWtvbFNWdnV4QVR5THBKSDdJd2x1aUtRdzFJN1h5VWhuTmxYWVZJRHRrakVaR0M0WURWSVlRLXZHV0dBQ1dSNHRkX2ktYnlfc1hfREd3STBKRnQ1Q25lbFd5TW1BX1FkeURnNW8xTnNJQnZMd25QbDdIMUJ0TE5IMnE2Z3FULWR5RUpFb2xCMk01N1NIT1UzdEI1YUpUMWd4TVA0ekw?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'AbbVie Acquires Oncology Drug Firm Pharmacyclics for $21 Billion', 'publisher': {'href': 'https://www.genengnews.com', 'title': 'Genetic Engineering & Biotechnology News'}, 'created_at': 'Thu, 05 Mar 2015 08:00:00 GMT', 'description': 'AbbVie Acquires Oncology Drug Firm Pharmacyclics for $21 Billion  Genetic Engineering & Biotechnology News', 'url': 'https://news.google.com/rss/articles/CBMikwFBVV95cUxOZk1GVG52NGN2Vk1la3pqeWJYeW1fcnFOemlCRFhMUmFDVzN4RVFibV83M19Wb0h5dkJyb3R5cGJTeEtjb29EME52R3lRck5TaE5KeFgwSC1RT0ZrT2VrMjh4WTQweDVsZy11Z2dGT2FMaTZ6NTBJMWdHaU43bE13V1ZfMGVnN3lXdWxZWGQ2NURoZFE?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Pharmacyclics (PCYC) Stock Spikes Today Following $21 Billion AbbVie Merger Deal', 'publisher': {'href': 'https://www.thestreet.com', 'title': 'TheStreet'}, 'created_at': 'Thu, 05 Mar 2015 08:00:00 GMT', 'description': 'Pharmacyclics (PCYC) Stock Spikes Today Following $21 Billion AbbVie Merger Deal  TheStreet', 'url': 'https://news.google.com/rss/articles/CBMivAFBVV95cUxNM3JCTXBTQzdSV0dQM0V5OXpoSjBDMkVWNC1qMVBlU3lNTWdRVmYwd1dMLWVndjM4MGxiX0R5M3d0Y3I4T0NneTE1QS1nVTZTRFozZjl5c2MxSXhyVHlLZE1BNzlNNUtoTGRrOE9odkd2YkVWdDhmaVJQZ0tWSFFVVW14bFlaLXhjTXU3eThNeEliUEotRGNvY3ZwaGdxVkJnOVhocEhjd2VHRGU2bVRTaVA3YXlnVmVscFJsQQ?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Dealmaker of the Week: David Lam of Wachtell', 'publisher': {'href': 'https://www.law.com', 'title': 'Law.com'}, 'created_at': 'Fri, 06 Mar 2015 08:00:00 GMT', 'description': 'Dealmaker of the Week: David Lam of Wachtell  Law.com', 'url': 'https://news.google.com/rss/articles/CBMioAFBVV95cUxNMkpzZ1VZdXhVYlpvWFlETl9JTnRxYXBGdmdMQ0NUN0V3ZC1yY3dEUFAyM0NzX3dFeHhVbDA2b3Z3dEExUkg1QXpicUN6OTZUQWxlNmZiSkF4TUxFYjdXa2JmbGcyZThVTkZGdW00QVBnenItbHZtejlvcnMxYmx0b3QwX05idDVTRWRlWDV2RGpNaXRoc2lKNENTOTFGMUlF?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'AbbVie swoops for Pharmacyclics in $21bn takeover', 'publisher': {'href': 'https://pharmaphorum.com', 'title': 'pharmaphorum'}, 'created_at': 'Thu, 05 Mar 2015 08:00:00 GMT', 'description': 'AbbVie swoops for Pharmacyclics in $21bn takeover  pharmaphorum', 'url': 'https://news.google.com/rss/articles/CBMihAFBVV95cUxPek5nY0NDcnRHMlBINXQyTTJBWW01V1RjMUt0ZDczUXZJZURaVWR6VjJIRDRBdjBFSWRWZjl0c0NyQjhRLTJYOERDUmkyNExfR3BIbFo2SC0zU3ZMSmd3c1hTWmNfOTJZdGpKWUdYajJESmFDOUhIS0NfQi1WX3QyRll3VHc?oc=5&hl=en-US&gl=US&ceid=US:en'}
